CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. Its products include QL Care Analyzer, Immunoassay Tests and Paramagnetic Beads. The company was founded by Yahia A. Gawad on November 20, 1997 and is headquartered in Mississauga, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cardiogenics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cardiogenics Holdings Inc market cap is $12,023.00.
What is the 52-week high for Cardiogenics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cardiogenics Holdings Inc 52 week high is $0.0002 as of April 06, 2026.
What is Cardiogenics Holdings Inc stock price today?
Cardiogenics Holdings Inc stock price today is $0.0001.